My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2017/1378 of 25 July 2017 renewing the approval of coumatetralyl as an active substance for use in biocidal products of product-type 14 (Text with EEA relevance. )

Commission Implementing Regulation (EU) 2017/1378 of 25 July 2017 renewing the approval of coumatetralyl as an active substance for use in biocidal products of product-type 14 (Text with EEA relevance. )

Implementing Regulation (EU) 2017/1378 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The approval of coumatetralyl as an active substance for use in biocidal products of product-type 14 is renewed, subject to the specifications and conditions set out in the Annex.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Expiry date of approval Product type Specific conditions Coumatetralyl IUPAC Name: 4-hydroxy-3-(1, 2, 3, 4-tetrahydro-1-naphthyl)coumarin EC No: 227-424-0 CAS No: 5836-29-3 980 g/kg 30 June 2024 14 Coumatetralyl is considered a candidate for substitution in accordance with points (a) and (e) of Article 10(1) of Regulation (EU) No 528/2012. The authorisations of biocidal products are subject to the following general conditions: (1) The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance. In addition, pursuant to point 10 of Annex VI to Regulation (EU) No 528/2012, the product assessment shall include an evaluation as to whether the conditions of Article 5(2) of Regulation (EU) No 528/2012 can be satisfied. (2) Products shall only be authorised for use in Member States where at least one of the conditions set out in Article 5(2) of Regulation (EU) No 528/2012 is satisfied. (3) The nominal concentration of coumatetralyl in the products shall not exceed 375 mg/kg in products other than contact formulations and shall not exceed 4 000 mg/kg in contact formulations. (4) Products shall contain an aversive agent and a dye. (5) Products shall not be authorised in the form of tracking powder. (6) Products in the form of contact formulations, other than tracking powder, shall only be authorised for use by trained professionals indoors in places not accessible to children or non-target animals. (7) Products shall not be authorised for use in permanent or pulse baiting treatments. (8) Only ready-to-use products shall be authorised. (9) Primary as well as secondary exposure of humans, non-target animals and the environment are minimised, by considering and applying all appropriate and available risk mitigation measures. These include for example the restriction to professional or trained professional use when possible and setting additional specific conditions per user category. (10) Dead bodies and uneaten bait shall be disposed of in accordance with local requirements. The method of disposal shall be described specifically in the summary of the product characteristics of the national authorisation and be reflected on the product label. In addition to the general conditions, the authorisations of biocidal products to be used by the general public are subject to the following conditions: (1) Products shall only be authorised for use in tamper-resistant bait stations. (2) Products shall only be supplied with a maximum quantity of bait per pack of: (a) for products against mice only: (i) For grain, pellet or paste baits: 250 g; (ii) For wax block baits: 500 g; (b) for products against rats only, or mice and rats: (i) for grain, pellet or paste baits: 750 g; (ii) for wax block baits: 1 500 g. (3) Products against Rattus norvegicus and Rattus rattus shall only be authorised for use indoors or in and around buildings. (4) Products against Mus musculus shall only be authorised for use indoors. (5) Persons making products available on the market shall ensure that the products are accompanied by information on the risks associated with anticoagulant rodenticides in general, measures to limit their use to the minimum necessary and appropriate precautionary steps to be taken. (6) Products in the form of loose bait formulations, such as grain or pellets, shall only be authorised in formulations that are supplied in sachets or other packaging to reduce exposure to humans and the environment. In addition to the general conditions, the authorisations of biocidal products to be used by professionals are subject to the following conditions: (1) Products shall not be authorised for use in sewers, open area or waste dumps. (2) Products shall only be authorised for use in tamper-resistant bait stations. (3) Persons making products for professional users available on the market shall make sure that these products are not supplied to the general public. In addition to the general conditions, the authorisations of biocidal products to be used by trained professionals are subject to the following conditions: (1) Products may be authorised for use in sewers, open area or waste dumps. (2) Products may be authorised for use in covered and protected bait points as long as they provide the same level of protection for non-target species and humans as tamper-resistant bait stations. (3) Persons making products for trained professional users available on the market shall make sure that the products are not supplied to other persons than trained professionals. ( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

Other acts of the same type
Council Regulation (EU) 2026/1891 of 30 July 2026 amending Regulation (EU) 2023/1529 concerning restrictive measures in view of Iran’s military support to Russia’s war of aggression against Ukraine and to armed groups and entities in the Middle East and the Red Sea region as well as Iran’s actions undermining freedom of navigation in the Middle EastCommission Implementing Regulation (EU) 2026/1893 of 30 July 2026 suspending commercial rebalancing measures concerning certain products originating in the United States of America and certain products exported from the Union to the United States of America imposed by Implementing Regulation (EU) 2025/1564Council Implementing Regulation (EU) 2026/1895 of 30 July 2026 implementing Regulation (EU) 2020/1998 concerning restrictive measures against serious human rights violations and abusesCommission Implementing Regulation (EU) 2026/1908 of 30 July 2026 amending Annex I to Implementing Regulation (EU) 2023/594 laying down special disease control measures for African swine feverCommission Regulation (EU) 2026/1825 of 29 July 2026 amending Regulation (EU) 2023/915 as regards maximum levels of 3-monochloropropanediol (3-MCPD), 3-MCPD fatty acid esters and glycidyl fatty acid esters in certain foodsCommission Implementing Regulation (EU) 2026/1859 of 29 July 2026 concerning the renewal of the authorisation of a preparation of taurine as a feed additive for Canidae, Felidae, Mustelidae, carnivorous finfish and other aquatic carnivorous species and repealing Implementing Regulation (EU) 2015/722Commission Implementing Regulation (EU) 2026/1860 of 29 July 2026 concerning the authorisation of a preparation of narasin (Monteban G100) as a feed additive for chickens for fattening (holder of authorisation: Elanco GmbH) and repealing Regulation (EC) No 1464/2004Commission Implementing Regulation (EU) 2026/1864 of 29 July 2026 specifying the technical items of the data set, establishing the technical formats for transmission of information and specifying the arrangements and content of the quality reports on the organisation of a sample survey in the use of information and communication technologies domain for reference year 2027 pursuant to Regulation (EU) 2019/1700 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/1865 of 29 July 2026 concerning the authorisation of thyme essential oil from Thymus vulgaris L. and/or Thymus zygis L. as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2026/1872 of 29 July 2026 amending the implementing technical standards laid down in Implementing Regulation (EU) 2016/2070 as regards benchmark portfolios, reporting templates and reporting instructions to be applied in the Union for the reporting referred to in Article 78(2) of Directive 2013/36 /EU of the European Parliament and of the CouncilCommission Regulation (EU) 2026/1890 of 29 July 2026 amending Regulation (EU) 2023/915 as regards maximum levels of the sum of furan, 2-methylfuran and 3-methylfuran in processed cereal-based food for infants and young children and in baby foodCommission Implementing Regulation (EU) 2026/1824 of 28 July 2026 making imports of lysine originating in the People’s Republic of China subject to registration with a view to allowing the levy of anti-dumping duties on the imports subject to registration

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next